{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:56:30Z","timestamp":1793138190601,"version":"4.5.0"},"reference-count":125,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Nonalcoholic steatohepatitis (NASH)-related cirrhosis has become one of the most common indications for liver transplantation (LT), particularly in candidates older than 65 years. Typically, NASH candidates have concurrent obesity, metabolic, and cardiovascular risks, which directly impact patient evaluation and selection, waitlist morbidity and mortality, and eventually posttransplant outcomes. The purpose of these guidelines is to highlight specific features commonly observed in NASH candidates and strategies to optimize pretransplant evaluation and waitlist survival. More specifically, the working group addressed the following clinically relevant questions providing recommendations based on the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system supported by rigorous systematic reviews and consensus: (1) Is the outcome after LT similar to that of other etiologies of liver disease? (2) Is the natural history of NASH-related cirrhosis different from other etiologies of end-stage liver disease? (3) How should cardiovascular risk be assessed in the candidate for LT? Should the assessment differ from that done in other etiologies? (4) How should comorbidities (hypertension, diabetes, dyslipidemia, obesity, renal dysfunction, etc.) be treated in the candidate for LT? Should treatment and monitoring of these comorbidities differ from that applied in other etiologies? (5) What are the therapeutic strategies recommended to improve the cardiovascular and nutritional status of a NASH patient in the waiting list for LT? (6) Is there any circumstance where obesity should contraindicate LT? (7) What is the optimal time for bariatric surgery: before, during, or after LT? (8) How relevant is donor steatosis for LT in NASH patients?<\/jats:p>","DOI":"10.1097\/tp.0000000000002433","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T03:38:09Z","timestamp":1535600289000},"page":"45-56","source":"Crossref","is-referenced-by-count":83,"title":["International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation"],"prefix":"10.1097","volume":"103","author":[{"given":"Emmanuel","family":"Tsochatzis","sequence":"first","affiliation":[{"name":"UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Coilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Nadalin","sequence":"additional","affiliation":[{"name":"Transplant and HBP Surgery Program, University Hospital Tuebingen, Tuebingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levistky","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaman","family":"Tokat","sequence":"additional","affiliation":[{"name":"Department of Liver Transplantation, Florence Nightingale Hospital, Sisli, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"Sherrie and Alan Conover Center for Liver Disease and Transplantation, Weill Cornell Medical College, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Klinck","sequence":"additional","affiliation":[{"name":"Anaesthesia, Division of Perioperative Care, Cambridge University Hospitals, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","year":"2004","journal-title":"BMJ"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2013.09.023","article-title":"Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"12","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","year":"2011","journal-title":"Gastroenterology"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lt.22435","article-title":"Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States","volume":"18","year":"2012","journal-title":"Liver Transpl"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s10620-017-4684-x","article-title":"Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes","volume":"62","year":"2017","journal-title":"Dig Dis Sci"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/ctr.12364","article-title":"Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data","volume":"28","year":"2014","journal-title":"Clin Transpl"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/TP.0000000000000945","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States","volume":"100","year":"2016","journal-title":"Transplantation"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/TP.0000000000002043","article-title":"Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma","volume":"102","year":"2018","journal-title":"Transplantation"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.TP.0000436723.59879.01","article-title":"Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation","volume":"96","year":"2013","journal-title":"Transplantation"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/SLA.0b013e31826b4b7e","article-title":"Liver transplantation for nonalcoholic steatohepatitis: the new epidemic","volume":"256","year":"2012","journal-title":"Ann Surg"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MCG.0b013e3181eeaff0","article-title":"The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes","volume":"45","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/lt.22382","article-title":"Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens?","volume":"17","year":"2011","journal-title":"Liver Transpl"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"E606","DOI":"10.1111\/j.1399-0012.2011.01497.x","article-title":"Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more","volume":"25","year":"2011","journal-title":"Clin Transplant"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.25855","article-title":"Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events","volume":"56","year":"2012","journal-title":"Hepatology"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/lt.21927","article-title":"Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1477-2574.2012.00497.x","article-title":"Equivalent survival following liver transplantation in patients with non\u2013alcoholic steatohepatitis compared with patients with other liver diseases","volume":"14","year":"2012","journal-title":"HPB (Oxford)"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1600-6143.2009.02590.x","article-title":"Outcome after liver transplantation for NASH cirrhosis","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib18-20231002","first-page":"66","article-title":"Hepatic venous pressure gradient (HVPG) predicts clinical disease progression in patients with compensated cirrhosis due to NASH","volume":"244A","year":"2017","journal-title":"Hepatology"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/jhep.2003.50320","article-title":"Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-1746.2008.05640.x","article-title":"Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C","volume":"24","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21103","article-title":"Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.cgh.2011.04.007","article-title":"Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants","volume":"9","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/lt.24507","article-title":"Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma","volume":"22","year":"2016","journal-title":"Liver Transpl"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","year":"2018","journal-title":"J Hepatol"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/ajt.12915","article-title":"Evaluation of solid organ transplant candidates for coronary artery disease","volume":"14","year":"2014","journal-title":"Am J Transplant"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1464-5491.2006.01817.x","article-title":"Increased prevalence of cardiovascular disease in Type 2 diabetic patients with nonalcoholic fatty liver disease","volume":"23","year":"2006","journal-title":"Diabet Med"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCA.0b013e3282583c0d","article-title":"Association between nonalcoholic fatty liver disease and coronary artery disease","volume":"18","year":"2007","journal-title":"Coron Artery Dis"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/ajg.2009.238","article-title":"The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans","volume":"104","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.arcmed.2009.07.009","article-title":"High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease","volume":"40","year":"2009","journal-title":"Arch Med Res"},{"issue":"Suppl 1","key":"bib31-20231002","first-page":"53","article-title":"Coronary artery disease and liver transplantation: the state of the art","volume":"6","year":"2000","journal-title":"Liver Transpl"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/lt.24987","article-title":"Cardiac function, a key component in evaluation for liver transplant","volume":"24","year":"2018","journal-title":"Liver Transpl"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International Liver Transplant Society Practice Guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","year":"2016","journal-title":"Transplantation"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/TP.0000000000001710","article-title":"Incidence of and risk assessment for adverse cardiovascular outcomes after liver transplantation: a systematic review","volume":"101","year":"2017","journal-title":"Transplantation"},{"key":"bib35-20231002","first-page":"30484","article-title":"Pretransplant coronary artery disease is a predictor for myocardial infarction and cardiac death after liver transplantation","volume":"S0953-6205","year":"2017","journal-title":"Eur J Intern Med"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"e006971","DOI":"10.1136\/bmjopen-2014-006971","article-title":"Time-varying impact of comorbidities on mortality after liver transplantation: a national cohort study using linked clinical and administrative data","volume":"5","year":"2015","journal-title":"BMJ Open"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.108.847178","article-title":"Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery","volume":"120","year":"2009","journal-title":"Circulation"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/TP.0b013e318198d734","article-title":"Prediction of cardiac complications after liver transplantation","volume":"87","year":"2009","journal-title":"Transplantation"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1600-6143.2009.02589.x","article-title":"Clinical burden of screening asymptomatic patients for coronary artery disease prior to liver transplantation","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/lt.25012","article-title":"Coronary artery disease in decompensated patients undergoing liver transplantation evaluation","volume":"24","year":"2018","journal-title":"Liver Transpl"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.114.009278","article-title":"Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study","volume":"130","year":"2014","journal-title":"Circulation"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIR.0000000000000105","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"130","year":"2014","journal-title":"Circulation"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2010.11.003","article-title":"The heart in liver transplantation","volume":"54","year":"2011","journal-title":"J Hepatol"},{"key":"bib44-20231002","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1600-6143.2008.02276.x","article-title":"Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates","volume":"8","year":"2008","journal-title":"Am J Transplant"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/00007890-199604270-00011","article-title":"Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"bib46-20231002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/lt.23997","article-title":"Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients","volume":"21","year":"2015","journal-title":"Liver Transpl"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s10554-013-0275-x","article-title":"Dobutamine stress echocardiography in patients undergoing orthotopic liver transplantation: a pooled analysis of accuracy, perioperative and long term cardiovascular prognosis","volume":"29","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"key":"bib48-20231002","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/clc.22283","article-title":"Utility of dobutamine stress echocardiography as part of the pre-liver transplant evaluation: an evaluation of its efficacy","volume":"37","year":"2014","journal-title":"Clin Cardiol"},{"key":"bib49-20231002","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9149(01)02244-5","article-title":"Predictive value of stress myocardial perfusion imaging in liver transplant candidates","volume":"89","year":"2002","journal-title":"Am J Cardiol"},{"key":"bib50-20231002","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.amjcard.2012.12.023","article-title":"Accuracy of stress myocardial perfusion imaging to diagnose coronary artery disease in end stage liver disease patients","volume":"111","year":"2013","journal-title":"Am J Cardiol"},{"key":"bib51-20231002","doi-asserted-by":"crossref","first-page":"e13222","DOI":"10.1111\/ctr.13222","article-title":"Dobutamine stress echocardiography, myocardial perfusion scintigraphy, invasive coronary angiography, and post-liver transplantation events: systematic review and meta-analysis","volume":"32","year":"2018","journal-title":"Clin Transplant"},{"key":"bib52-20231002","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/lt.23873","article-title":"Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation","volume":"20","year":"2014","journal-title":"Liver Transpl"},{"key":"bib53-20231002","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-6143.2012.04293.x","article-title":"Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib54-20231002","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/TP.0000000000001647","article-title":"Outcome of liver transplant recipients with revascularized coronary artery disease: a comparative analysis with and without cardiovascular risk factors","volume":"101","year":"2017","journal-title":"Transplantation"},{"key":"bib55-20231002","doi-asserted-by":"crossref","first-page":"438","DOI":"10.14503\/THIJ-14-4738","article-title":"Coronary interventions before liver transplantation might not avert postoperative cardiovascular events","volume":"42","year":"2015","journal-title":"Tex Heart Inst J"},{"key":"bib56-20231002","doi-asserted-by":"crossref","first-page":"e005102","DOI":"10.1161\/JAHA.116.005102","article-title":"Predictive value of dobutamine stress perfusion echocardiography in contemporary end-stage liver disease","volume":"6","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"bib57-20231002","first-page":"4081525","article-title":"Coronary computed tomography angiography in combination with coronary artery calcium scoring for the preoperative cardiac evaluation of liver transplant recipients","volume":"2017","year":"2017","journal-title":"Biomed Res Int"},{"key":"bib58-20231002","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/lt.21540","article-title":"Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"bib59-20231002","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.ejrad.2011.05.009","article-title":"Coronary computer tomographic angiography for preoperative risk stratification in patients undergoing liver transplantation","volume":"81","year":"2012","journal-title":"Eur J Radiol"},{"key":"bib60-20231002","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/bja\/aeu384","article-title":"Preoperative coronary calcium score is predictive of early postoperative cardiovascular complications in liver transplant recipients","volume":"114","year":"2015","journal-title":"Br J Anaesth"},{"key":"bib61-20231002","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/lt.23950","article-title":"High early cardiovascular mortality after liver transplantation","volume":"20","year":"2014","journal-title":"Liver Transpl"},{"key":"bib62-20231002","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1053\/jlts.2001.26063","article-title":"Detection and treatment of coronary artery disease in liver transplant candidates","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"bib63-20231002","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/lt.21660","article-title":"Reducing coronary artery disease events in liver transplant patients: moving toward identifying the vulnerable patient","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"bib64-20231002","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00007890-199503270-00010","article-title":"The prevalence of coronary artery disease in liver transplant candidates over age 50","volume":"59","year":"1995","journal-title":"Transplantation"},{"key":"bib65-20231002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"bib66-20231002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11894-017-0584-7","article-title":"Use of statins in patients with chronic liver disease and cirrhosis: current views and prospects","volume":"19","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"bib67-20231002","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2015.05.006","article-title":"Statin use and non-alcoholic steatohepatitis in at risk individuals","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"bib68-20231002","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","article-title":"A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease","volume":"40","year":"2008","journal-title":"Dig Liver Dis"},{"key":"bib69-20231002","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/liv.12611","article-title":"Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease","volume":"35","year":"2015","journal-title":"Liver Int"},{"key":"bib70-20231002","doi-asserted-by":"crossref","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","year":"2014","journal-title":"PLoS Med"},{"key":"bib71-20231002","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/lt.24128","article-title":"Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients","volume":"21","year":"2015","journal-title":"Liver Transpl"},{"key":"bib72-20231002","article-title":"Cardiovascular disease outcomes related to early stage renal impairment following liver transplantation","journal-title":"Transplantation"},{"key":"bib73-20231002","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.29329","article-title":"A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score","volume":"66","year":"2017","journal-title":"Hepatology"},{"key":"bib74-20231002","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/TP.0000000000001399","article-title":"Controlling diabetes after liver transplantation: room for improvement","volume":"100","year":"2016","journal-title":"Transplantation"},{"key":"bib75-20231002","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/TP.0b013e31824cd5e6","article-title":"Control of blood pressure in liver transplant recipients","volume":"93","year":"2012","journal-title":"Transplantation"},{"key":"bib76-20231002","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/SLA.0b013e3181a77d00","article-title":"Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV)","volume":"249","year":"2009","journal-title":"Ann Surg"},{"key":"bib77-20231002","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"bib78-20231002","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/00000542-200612000-00027","article-title":"Improved postoperative outcomes associated with preoperative statin therapy","volume":"105","year":"2006","journal-title":"Anesthesiology"},{"key":"bib79-20231002","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.21848","article-title":"Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"bib80-20231002","article-title":"Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation","journal-title":"Liver Transpl"},{"key":"bib81-20231002","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/jhep.2002.30318","article-title":"Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"bib82-20231002","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00007890-200210150-00019","article-title":"The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation","volume":"74","year":"2002","journal-title":"Transplantation"},{"key":"bib83-20231002","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"bib84-20231002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1756283X09105462","article-title":"The Effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial","volume":"2","year":"2009","journal-title":"Therap Adv Gastroenterol"},{"key":"bib85-20231002","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"bib86-20231002","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"bib87-20231002","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"bib88-20231002","first-page":"734","article-title":"Protein-calorie malnutrition and the etiology of cirrhosis","volume":"92","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"bib89-20231002","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.28132","article-title":"Physical activity and liver diseases","volume":"63","year":"2016","journal-title":"Hepatology"},{"key":"bib90-20231002","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.28992","article-title":"Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study","volume":"65","year":"2017","journal-title":"Hepatology"},{"key":"bib91-20231002","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ejcn.2013.45","article-title":"Malnutrition risk in newly hospitalized overweight and obese individuals: Mr NOI","volume":"67","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"bib92-20231002","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/TP.0000000000000245","article-title":"Personalized adapted physical activity before liver transplantation: acceptability and results","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"bib93-20231002","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.cgh.2014.04.016","article-title":"Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis","volume":"12","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib94-20231002","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s11695-016-2123-2","article-title":"Prevalence of liver fibrosis and its association with non-invasive fibrosis and metabolic markers in morbidly obese patients with vitamin D deficiency","volume":"26","year":"2016","journal-title":"Obes Surg"},{"key":"bib95-20231002","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1600-6143.2007.02100.x","article-title":"The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database","volume":"8","year":"2008","journal-title":"Am J Transpl"},{"key":"bib96-20231002","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s10620-014-3469-8","article-title":"Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation","volume":"60","year":"2015","journal-title":"Dig Dis Sci"},{"key":"bib97-20231002","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/lt.21785","article-title":"Liver transplantation at the extremes of the body mass index","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"bib98-20231002","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/liv.13523","article-title":"Weighing the risks: morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list","volume":"38","year":"2018","journal-title":"Liver Int"},{"key":"bib99-20231002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/liv.12431","article-title":"The impact of obesity on patient survival in liver transplant recipients: a meta-analysis","volume":"35","year":"2015","journal-title":"Liver Int"},{"key":"bib100-20231002","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.dld.2017.07.004","article-title":"Obesity as predictor of postoperative outcomes in liver transplant candidates: review of the literature and future perspectives","volume":"49","year":"2017","journal-title":"Dig Liver Dis"},{"key":"bib101-20231002","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1399-0012.2004.00141.x","article-title":"Impact of body mass index on graft failure and overall survival following liver transplantation","volume":"18","year":"2004","journal-title":"Clin Transplant"},{"key":"bib102-20231002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/hpb.12340","article-title":"Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysis","volume":"17","year":"2015","journal-title":"HPB (Oxford)"},{"key":"bib103-20231002","first-page":"77","article-title":"Survival benefit of kidney and liver transplantation for obese patients on the waiting list","volume":"17","year":"2003","journal-title":"Clin Transpl"},{"key":"bib104-20231002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/tri.12483","article-title":"Impact of recipient morbid obesity on outcomes after liver transplantation","volume":"28","year":"2015","journal-title":"Transpl Int"},{"key":"bib105-20231002","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/apt.12881","article-title":"The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US","volume":"40","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"bib106-20231002","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/lt.23818","article-title":"Additive effect of pre- transplantation obesity, diabetes, and cardiovascular risk factors on outcomes after liver transplantation","volume":"20","year":"2014","journal-title":"Liver Transpl"},{"key":"bib107-20231002","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/lt.23618","article-title":"Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom","volume":"19","year":"2013","journal-title":"Liver Transpl"},{"key":"bib108-20231002","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1399-0012.2012.01669.x","article-title":"Complications associated with liver transplantation in the obese recipient","volume":"26","year":"2012","journal-title":"Clin Transplant"},{"key":"bib109-20231002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.soard.2007.12.009","article-title":"Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation","volume":"4","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"bib110-20231002","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.soard.2013.02.013","article-title":"Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates","volume":"9","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"bib111-20231002","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0952-8180(96)00142-0","article-title":"Liver transplantation in the morbidly obese","volume":"8","year":"1996","journal-title":"J Clin Anesth"},{"key":"bib112-20231002","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-6143.2012.04318.x","article-title":"Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib113-20231002","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11695-008-9432-z","article-title":"Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation","volume":"17","year":"2007","journal-title":"Obes Surg"},{"key":"bib114-20231002","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00464-012-2410-5","article-title":"Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation","volume":"27","year":"2013","journal-title":"Surg Endosc"},{"key":"bib115-20231002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11695-014-1430-8","article-title":"Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery","volume":"25","year":"2015","journal-title":"Obes Surg"},{"key":"bib116-20231002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.soard.2013.07.015","article-title":"Bariatric surgery trends in France: 2005\u20132011","volume":"10","year":"2014","journal-title":"Surg Obes Relat Dis"},{"key":"bib117-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soard.2012.07.021","article-title":"Bariatric surgery in patients with liver cirrhosis","volume":"9","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"bib118-20231002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1381\/096089204772787284","article-title":"Results of laparoscopic gastric bypass in patients with cirrhosis","volume":"14","year":"2004","journal-title":"Obes Surg"},{"key":"bib119-20231002","first-page":"1359","article-title":"Bariatric surgery and end-stage organ failure","volume":"96","year":"2013","journal-title":"Surg Clin North Am"},{"key":"bib120-20231002","article-title":"Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy","journal-title":"Hepatology"},{"key":"bib121-20231002","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jlts.2001.23787","article-title":"Body mass index as a predictor of hepatic steatosis in living liver donors","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"bib122-20231002","first-page":"35","article-title":"Liver biopsy results in potential donor evaluation in living related liver transplant","volume":"16","year":"2018","journal-title":"Exp Clin Transplant"},{"key":"bib123-20231002","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"EASL Clinical Practice Guidelines: Liver transplantation","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"bib124-20231002","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s11605-015-2832-1","article-title":"Donor hepatic steatosis and outcome after liver transplantation: a systematic review","volume":"19","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"bib125-20231002","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/SLA.0b013e318272dea2","article-title":"The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score","volume":"256","year":"2012","journal-title":"Ann Surg"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201901000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:18:45Z","timestamp":1696223925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201901000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002433","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}